Allergies News and Research

Latest Allergies News and Research

Boosting immune response could increase inflammation

People often talk about "boosting" their immunity to prevent and fight colds. Nutritional supplements, cold remedies and fortified foods claim to stave off colds by augmenting the immune system.

16 Jun 2011

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Meda presents new positive results from a Phase-III clinical trial of Dymista at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in Istanbul, Turkey.

15 Jun 2011

Abbott’s CREON receives FDA approval for infant-specific dose

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.

14 Jun 2011

Science Speaks series interviews key players in global AIDS fight

In the final installment of a series recognizing the 30th anniversary of AIDS on the Center for Global Health Policy's "Science Speaks" blog, John Donnelly interviews Warren "Buck" Buckingham, director of the Office of AIDS Relief at the Peace Corps, about his work in the field.

14 Jun 2011

New molecular diagnostic test precisely identifies insect venom allergy

Bees, wasps and bumble bees pose a real health threat to individuals with venom allergy. One sting from these insects may cause potentially life-threatening anaphylactic reactions in people with these conditions.

14 Jun 2011

Cinryze data on hereditary angioedema presented at EAACI 2011

ViroPharma Incorporated today announced that data relating to Cinryze from nine accepted abstracts were presented as poster presentations at the 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI), June 11 through 15, in Istanbul, Turkey.

14 Jun 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.

14 Jun 2011

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical trial showing that patients who received four doses of its ToleroMune cat allergy vaccine over a 12-week period maintained a statistically significant reduction in symptoms one year later.

13 Jun 2011

Study finds no link between early exposure to pets and children's risk of allergies

A new study published in the journal Clinical & Experimental Allergy reveals that keeping a dog or cat in the home does not increase children's risk of becoming allergic to the pets.

13 Jun 2011

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Biota Holdings Limited advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

10 Jun 2011

NIH awards $1.9M grant to Scripps Research scientist for malaria study

A scientist from The Scripps Research Institute has won a four-year, $1.9 million grant from the National Institutes of Health to better understand the parasite that causes malaria, laying the groundwork to develop better drugs to combat the widespread and deadly disease.

10 Jun 2011

Media examine HIV/AIDS epidemic as U.N. meeting prepares to convene

This week, political leaders will gather in New York at the U.N. High Level Meeting on AIDS to "frame the ongoing fight against HIV/AIDS," Nature News reports. The article includes a Q&A with Anthony Fauci, head of the NIH National Institute of Allergy and Infectious Diseases, who "explains what scientists hope the U.N. meeting will achieve".

9 Jun 2011

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

Spring and summer bring bees, wasps, hornets and yellow jackets and, this year, updated advice for those who are allergic to these pesky stinging insects. More than half a million people go to emergency rooms and at least 50 die each year from insect stings.

9 Jun 2011

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.

8 Jun 2011

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

Hospitals, nursery schools, and other high-traffic indoor spaces have been acting as quiet proving grounds for an advanced new form of air purification. These are normally the kinds of places where germs, allergens and airborne toxins flourish. That's soon going to be a thing of the past.

7 Jun 2011

FDA accepts Sunovion ciclesonide HFA nasal aerosol NDA for review

Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.

6 Jun 2011

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.

6 Jun 2011

Allergies News and Research

Latest Allergies News and Research

Boosting immune response could increase inflammation

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Abbott’s CREON receives FDA approval for infant-specific dose

Science Speaks series interviews key players in global AIDS fight

New molecular diagnostic test precisely identifies insect venom allergy

Cinryze data on hereditary angioedema presented at EAACI 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Study finds no link between early exposure to pets and children's risk of allergies

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIH awards $1.9M grant to Scripps Research scientist for malaria study

Media examine HIV/AIDS epidemic as U.N. meeting prepares to convene

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

FDA accepts Sunovion ciclesonide HFA nasal aerosol NDA for review

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Scientists demonstrate why B cells exposed to chronic HIV shut down, how they can be reactivated

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Exposure to phthalates can cause children's allergy and asthma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in